A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity




TekijätHesse E, Saito H, Kiviranta R, Correa D, Yamana K, Neff L, Toben D, Duda G, Atfi A, Geoffroy V, Horne WC, Baron R

KustantajaROCKEFELLER UNIV PRESS

Julkaisuvuosi2010

JournalJournal of Cell Biology

Tietokannassa oleva lehden nimiJOURNAL OF CELL BIOLOGY

Lehden akronyymiJ CELL BIOL

Vuosikerta191

Numero7

Aloitussivu1271

Lopetussivu1283

Sivujen määrä13

ISSN0021-9525

DOIhttps://doi.org/10.1083/jcb.201009107


Tiivistelmä
Runx2 is indispensable for osteoblast lineage commitment and early differentiation but also blocks osteoblast maturation, thereby causing bone loss in Runx2 transgenic mice. Zinc finger protein 521 (Zfp521) antagonizes Runx2 in vivo. Eliminating one Zfp521 allele mitigates the cleidocranial dysplasia-like phenotype of newborn Runx2(+/-). mice, whereas overexpressing Zfp521 exacerbates it. Overexpressing Zfp521 also reverses the severe osteopenia of adult Runx2 transgenic mice. Zfp521 binds to both Runx2 and histone deacetylase 3 (HDAC3), promotes their association, and antagonizes Runx2 transcriptional activity in an HDAC3-dependent manner. Mutating the Zfp521 zinc finger domains 6 and 26 reduces the binding of Zfp521 to Runx2 and inhibition of Runx2 activity. These data provide evidence that Zfp521 antagonizes Runx2 in vivo and thereby regulates two stages of osteoblast development, early during mesenchymal cell lineage commitment and later during osteoblast maturation. Thus, the balance and molecular interplay between Zfp521 and Runx2 contribute to the control of osteoblast differentiation, skeletal development, and bone homeostasis.



Last updated on 2024-26-11 at 13:40